Stockreport

FDA agrees to single phase 3 trial by Entera for bone disorder drug EB613 to support approval [Seeking Alpha]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF FDA agrees to single phase 3 trial by Entera for bone disorder drug EB613 to support approvalOct. 06, 2022 8:35 AM ETEntera Bio Ltd. (ENTX)LLYBy:RavikashSA News Editor1 [Read more]